Pentapeptide-18
Cosmetic ingredientCosmetic signal peptide
Also known as: Leuphasyl, (D-Ala2)leucine-enkephalin, Tyr-D-Ala-Gly-Phe-Leu, H-Tyr-D-Ala-Gly-Phe-Leu-OH, (D-Ala2)-Leu-Enkephalin
Very thin human evidence
- Regulatory standing. Cosmetic ingredient, not regulated as a drug
- Animal / preclinical only. Evidence is largely animal or in-vitro
- No registered human trials. Nothing registered on ClinicalTrials.gov
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Pentapeptide-18, sold under the trade name Leuphasyl, is a short synthetic peptide used as an ingredient in topical skincare products. It is designed to mimic enkephalins and is thought to reduce nerve signaling to facial muscles, which manufacturers suggest may soften expression lines when applied to the skin.
What the evidence shows
There are no registered human clinical trials, and the small published literature consists mainly of lab work and manufacturer-linked cosmetic studies. Whether it meaningfully reduces wrinkles in people is not well established.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
D-tyrosine adds an anti-melanogenic effect to cosmetic peptides.
Solid Lipid Nanoparticles Incorporated with Retinol and Pentapeptide-18-Optimization, Characterization, and Cosmetic Application.
Retinol and Oligopeptide-Loaded Lipid Nanocarriers as Effective Raw Material in Anti-Acne and Anti-Aging Therapies.
Sources
- PubChem compound record (CID 10099522)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.